Named on one round in the feed.
Since 2021-03-04
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
TytoCare The remote examination company is shifting focus from low-acuity primary care toward cardiopulmonary and oncology support | Series D+ ext. Verified against 1 source[ HISTORY ]: An earlier round of this company, found through its checked dossier and read from its own announcement like any round. Not news: never sent, and left out of the feed unless you filter by date. | $50M | 2021-03-04 | [ PART ] |